cmi_logo.png
[Latest] Global Event Logistics Market Size/Share Worth USD 87.8 Billion by 2033 at a 4.8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
September 03, 2024 10:30 ET | Custom Market Insights
Austin, TX, USA, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Event Logistics Market Size, Trends and Insights By Type (Inventory Management,...
RNAZ White background cropped.jpg
TransCode Therapeutics, Inc. Announces Pricing of Public Offering
July 22, 2024 22:30 ET | TransCode Therapeutics, Inc.
Boston, MA — July 22, 2024 — TransCode Therapeutics, Inc. (Nasdaq: RNAZ), (“TransCode” or the “Company”), a clinical-stage RNA oncology company committed t
RNAZ White background cropped.jpg
TransCode Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
July 22, 2024 16:07 ET | TransCode Therapeutics, Inc.
Boston, MA – July 22, 2024 – TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (“TransCode” or the “Company”), a clinical-stage RNA oncology company committed t
Unleash Ultimate Summer Fun: Meaghan B. Murphy’s Comprehensive Summer Fun Guide
July 15, 2024 16:05 ET | D S Simon
NEW YORK, July 15, 2024 (GLOBE NEWSWIRE) -- Summer is upon us, and it’s the perfect time to soak up the sun, embrace new adventures, and create lasting memories. Meaghan B Murphy, author of Your...
Twist&Crispy
A Revolutionary Twist on Takeout and Delivery with New Twist & Crispy™ Containers from Sabert
June 04, 2024 08:05 ET | Sabert
SAYREVILLE, N.J., June 04, 2024 (GLOBE NEWSWIRE) -- Sabert Corporation, a leading global manufacturer of innovative food packaging, announces the launch of the groundbreaking Twist & Crispy™...
fulllogo_transparent_nobuffer Aanastra.png
Aanastra Inc to Showcase its Peptide-RNA Therapeutics Technology in Multiple Presentations at the American Society for Gene and Cell Therapies (ASGCT) Annual Meeting 2024
May 02, 2024 06:30 ET | Aanastra Inc
Aanastra showcases its peptide-RNA therapeutics targeting p53, KRAS and BRCA-1 driven cancers, hemophilia A and PCSK9 for hypercholestrolemia at ASGCT
Atari Logo.png
Atari Revives Infogrames as a Publishing Label
April 23, 2024 02:00 ET | Atari Inc.
Atari announces it is reviving Infogrames as a publishing label, starting with purchase of Totally Reliable Delivery Services from tinyBuild LLC.
RNAZ White background cropped.jpg
TransCode Therapeutics Announces FDA Clearance To Initiate Phase 1/2 Clinical Trial with TTX-MC138 in Patients with Advanced Solid Tumors
April 15, 2024 09:00 ET | TransCode Therapeutics, Inc.
TransCode Therapeutics Announces FDA Clearance To Initiate Phase 1/2 Clinical Trial with TTX-MC138 in Patients with Advanced Solid Tumors
RNAZ White background cropped.jpg
TransCode Therapeutics Reports 2023 Results; Provides Business Update
April 03, 2024 09:10 ET | TransCode Therapeutics, Inc.
TransCode Therapeutics Reports 2023 Results; Provides Business Update
RNAZ White background cropped.jpg
TransCode Therapeutics Announces Appointment of Daniel Vlock, M.D., as Chief Medical Officer
March 28, 2024 08:30 ET | TransCode Therapeutics, Inc.
TransCode Therapeutics Announces Appointment of Daniel Vlock, M.D., as Chief Medical Officer